Profile: Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

30 Jan 2015
Change (% chg)

$1.75 (+2.93%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Abaxis, Inc. (Abaxis), incorporated on January 12, 1989, develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The Company’s segments include the medical market and the veterinary market. The Company has developed a blood analysis system incorporating all of these criteria into a 5.1 kilogram (11.2 pounds) portable analyzer and a series of menu-specific, multi-test single-use reagent discs. Abaxis markets its blood chemistry analyzers in the medical market and in the veterinary market. The Company markets the blood analysis system in the medical market under the name Piccolo Xpress. It markets the blood analysis system in the veterinary market under the name VetScan VS2.

The Company product include blood analysis system, consisting of a compact portable analyzer and a series of single-use plastic discs, called reagent discs, containing all the chemicals required to perform a panel of up to 14 tests on human patients and 13 tests on veterinary patients. The reagent discs used with the blood chemistry analyzers are designed to handle almost all technical steps of blood chemistry testing automatically. The discs are 8-cm diameter, single-use devices constructed from three ultrasonically welded injection-molded plastic parts. The base and the middle piece create the chambers, cuvettes and passageways for processing the whole blood and mixing plasma with diluents and reagents. The top piece, referred to as the bar code ring, is imprinted with bar codes that contain disc-specific calibration information. In the center of the disc is a plastic diluents container sealed with polyethylene-laminated foil.

Medical market

In the medical market segment, Abaxis serve a worldwide customer group consisting of military installations (ships, field hospitals and mobile care units), physicians’ office practices across all specialties, urgent care, outpatient and walk-in clinics (free-standing or hospital-connected), health screening operations, home care providers (national, regional or local), nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies and hospital labs. The products manufactured and sold in this segment consist of Piccolo chemistry analyzers and medical reagent discs.

Veterinary Market

In the veterinary market segment, the Company serve a worldwide customer group consisting of companion animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies and private research laboratories. The products manufactured and sold in this segment consist of VetScan chemistry analyzers and veterinary reagent discs. It also sells original equipment manufacturer (OEM) supplied products in this segment consisting of VetScan hematology instruments and related reagent kits, VetScan VSpro coagulation and specialty analyzers and related consumables, rapid tests, and VetScan i-STAT analyzers and related VetScan i-STAT consumables

The Company competes with Alere, Alfa Wassermann S.P.A., Abbott Laboratories, i-STAT Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Idexx Laboratories, Inc. and Heska Corporation.

Company Address

Abaxis Inc

3240 Whipple Road
UNION CITY   CA   94587
P: +1510.6756500
F: +1510.4416150

Company Web Links

Search Stocks